Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
Ann N Y Acad Sci. 2024 Oct;1540(1):47-60. doi: 10.1111/nyas.15213. Epub 2024 Sep 13.
The neuropeptide kisspeptin and its cognate receptor have been extensively studied in reproductive physiology, with diverse and well-established functions, including as an upstream regulator of pubertal onset, reproductive hormone secretion, and sexual behavior. Besides classical reproduction, both kisspeptin and its receptor are extensively expressed in bone-resorbing osteoclasts and bone-forming osteoblasts, which putatively permits direct bone effects. Accordingly, this sets the scene for recent compelling findings derived from in vitro experiments through to in vivo and clinical studies revealing prominent regulatory interactions for kisspeptin signaling in bone metabolism, as well as certain oncological aspects of bone metabolism. Herein, we comprehensively examine the experimental evidence obtained to date supporting the interaction between kisspeptin and bone. A comprehensive understanding of this emerging facet of kisspeptin biology is fundamental to exploiting the future therapeutic potential of kisspeptin-based medicines as a novel strategy for treating bone-related disorders.
神经肽 kisspeptin 及其同源受体在生殖生理学中得到了广泛研究,具有多样化且成熟的功能,包括作为青春期开始、生殖激素分泌和性行为的上游调节剂。除了经典的生殖功能外,kisspeptin 和其受体还广泛表达于破骨细胞和成骨细胞中,这可能允许 kisspeptin 对骨骼产生直接作用。因此,这为最近的体外实验、体内实验和临床研究提供了有力的依据,这些研究揭示了 kisspeptin 信号在骨代谢中的显著调节作用,以及骨代谢的某些肿瘤学方面。在此,我们全面检查了迄今为止获得的支持 kisspeptin 与骨骼相互作用的实验证据。全面了解 kisspeptin 生物学这一新兴方面对于利用 kisspeptin 为基础的药物的未来治疗潜力至关重要,这是一种治疗与骨骼相关疾病的新型策略。